eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | atrial fibrillation |
| Comorbidity | C0020538|hypertension |
| Sentences | 29 |
| PubMedID- 23323124 | Some patients with an underlying pda may be highly symptomatic, presenting with congestive heart failure, pulmonary hypertension, signs of volume overload, atrial fibrillation, recurrent pneumonia, or other complications known to be associated with pda. |
| PubMedID- 24572913 | Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4a (angiotensin ii antagonist of platelet aggregation in patients with atrial fibrillation), a pilot study. |
| PubMedID- 22509440 | Four years ago, she had had mitral posterior annuloplasty (tailor ring 27 mm), tricuspid annuloplasty (an-core ring), and a maze operation, due to severe mitral regurgitation, moderate tricuspid regurgitation, and moderate resting pulmonary hypertension, combined with atrial fibrillation. |
| PubMedID- 24077242 | The importance of hypertension in patients with atrial fibrillation is recognized by its inclusion both in the cha2ds2-vasc (risk for stroke) and the has-bled (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs/alcohol concomitantly) scores (risk for bleeding) and the presence of hypertension alone is an indication to initiate antithrombotic treatment. |
| PubMedID- 21804774 | [52] also showed that patients with hypertension associated with non-valvular atrial fibrillation had a higher risk of embolic recurrence as compared to patients with only hypertension or with non-valvular atrial fibrillation only. |
| PubMedID- 21854635 | Calcium channel blockers are commonly prescribed for hypertension and rate control of atrial fibrillation, but can be highly toxic in large quantities. |
| PubMedID- 26102889 | 5a.07: prevalence of arterial hypertension in patients with atrial fibrillation undergoing ablation. |
| PubMedID- 20368796 | Additional medical diagnoses were hypertension with intermittent atrial fibrillation, left ventricular hypertrophy, pulmonary hypertension, visceral hypoperfusion, pyelonephritis, an old portal venous thrombosis, fatty liver, hyperuricemia and pulmonary embolism in 10/07. |
| PubMedID- 23990675 | Older age, female sex, african american race and hispanic ethnicity, unemployed status, diabetes, hypertension, history of stroke, and permanent atrial fibrillation were positively associated with ischemic stroke, whereas body mass index >30 kg/m(2) was inversely associated with stroke (p<0.001 for each). |
| PubMedID- 25830152 | After adjustment for multiple variables, including age, gender, hypertension, comorbidities, type of atrial fibrillation, left atrial volume, and left ventricular ejection fraction, the extent of atrial disease was the only significant predictor of atrial-fibrillation recurrence. |
| PubMedID- 24125845 | Recent clinical studies show that rd significantly attenuates muscle sympathetic nerve activity42 and improves cardiac hypertrophy and function,10 atrial fibrillation,11 glucose intolerance43 in patients with resistant hypertension, thereby supporting the concept that rd can have the benefit in prevention of cardiovascular injury through afferent renal nerve ablation. |
| PubMedID- 25093087 | Background: although hypertension is associated with atrial fibrillation (af), the impact of hypertension on the electromechanical properties and outcome of catheter ablation in af patients is unclear. |
| PubMedID- 21148662 | Dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (j-rhythm ii study). |
| PubMedID- 23733200 | Inclusion criteria were stable diabetes; absence of infections during the last month; absence of major cardiovascular complications such as coronary heart disease, unstable or stable angina, myocardial infarction, ventricular arrhythmias, and atrial fibrillation; therapy with β-blockers; severe hypertension (>180 mmhg systolic or >110 mmhg diastolic blood pressure); definite autonomic dysfunction; or proliferative retinopathy. |
| PubMedID- 23554744 | In summary, our findings suggest that treatment aimed at reducing plasma glucose and blood pressure in patients with hyperglycemia and hypertension, reducing the severity of atrial fibrillation, or lowering the level of ldl-c among acute ischemic stroke patients should be emphasized to reduce the risk of neurological deficiency or in-hospital death among acute ischemic stroke patients. |
| PubMedID- 24640727 | The risk of atrial fibrillation in patients with hypertension prognostic value are the only values of the age, the volume index of the left atrial to the body surface area and left ventricular ejection fraction. |
| PubMedID- 22641540 | Upstream therapy is the promising issue in the treatment of atrial fibrillation (af) especially in patients with arterial hypertension and heart failure. |
| PubMedID- 25827533 | Nine predictors (coronary artery disease, diabetes mellitus, hypertension, history of cerebrovascular disease, atrial fibrillation, smoking, the findings of carotid doppler ultrasonography [normal, plaque, plaque+stenosis>/=50%], the levels of cholesterol and c-reactive protein) were used for predicting the stroke. |
| PubMedID- 23631190 | The incidence of atrial fibrillation (af) is increased in patients with hypertension and high blood pressure is a well-known risk factor for af. |
| PubMedID- 23312360 | The association between pulmonary hypertension and lower risk of postoperative atrial fibrillation after lung transplantation. |
| PubMedID- 26282726 | hypertension is frequent in patients with atrial fibrillation (af) and is an independent risk factor for stroke. |
| PubMedID- 22753219 | Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the losartan intervention for endpoint (life) reduction in hypertension study. |
| PubMedID- 20072146 | The role of inflammation in maintenance of paroxysmal atrial fibrillation (paf) in patients with hypertension and no other heart disease has not been fully elucidated yet. |
| PubMedID- 25523937 | There was also an increased risk for atrial fibrillation among those with hypertension, and bmi was positively associated with an increased risk for atrial fibrillation (table 2). |
| PubMedID- 24799929 | Additional comorbidities included stable coronary artery disease, paroxysmal atrial fibrillation treated with oral anticoagulants, hypertension, hypercholesterolemia and severe pad with occlusion of the right common iliac artery treated with suprapubic femoro-femoral bypass in 2005 (figure 1). |
| PubMedID- 20930986 | Many patients will remain on coumadin indefinitely as they have an underlying pro-embolic condition such as atrial fibrillation.antihypertensive: patients with prior hypertension or with new-onset hypertension from the infarct should be treated with an anti-hypertensive. |
| PubMedID- 24133375 | Finally, rather than the relatively benign elevation of blood pressure previously considered to be the case, primary aldosteronism has been shown to have a much higher cardiovascular risk profile, including for nonfatal myocardial infarction, stroke, and atrial fibrillation, than that in patients with essential hypertension matched for age, gender, and blood pressure. |
| PubMedID- 25953603 | Nevertheless, we believe that selective survival might explain the inverse association between hypertension and the prevalence of atrial fibrillation in subjects older than 80 years. |
| PubMedID- 23331441 | Conclusion: statin therapy in elderly patients with hypertension reduces the risk of new-onset atrial fibrillation. |
Page: 1